Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors

被引：31
|
作者：
Abdallah, Abdallah E. [1 ]
Mabrouk, Reda R. [1 ]
Al Ward, Maged Mohammed Saleh [1 ]
Eissa, Sally, I [2 ,3 ]
Elkaeed, Eslam B. [3 ]
Mehany, Ahmed B. M. [4 ]
Abo-Saif, Mariam A. [5 ]
El-Feky, Ola A. [5 ]
Alesawy, Mohamed S. [1 ]
El-Zahabi, Mohamed Ayman [1 ]
机构：
[1] Al Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo, Egypt
[2] Al Azhar Univ, Fac Pharm Girls, Dept Pharmaceut Chem, Cairo, Egypt
[3] AlMaarefa Univ, Coll Pharm, Dept Pharmaceut Sci, Riyadh, Saudi Arabia
[4] Al Azhar Univ, Fac Sci, Zool Dept, Cairo, Egypt
[5] Tanta Univ, Fac Pharm, Biochem Dept, Tanta, Egypt
来源：
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 2022年 / 37卷 / 01期
关键词：
Anticancer; apoptosis; multi-kinase; pharmacophoric features; VEGFR-2; KINASE INHIBITORS; DISCOVERY; CANCER; DERIVATIVES; MECHANISMS; BINDING;
D O I：
10.1080/14756366.2021.2017911
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Based on quinazoline, quinoxaline, and nitrobenzene scaffolds and on pharmacophoric features of VEGFR-2 inhibitors, 17 novel compounds were designed and synthesised. VEGFR-2 IC50 values ranged from 60.00 to 123.85 nM for the new derivatives compared to 54.00 nM for sorafenib. Compounds 15(a) , 15(b) , and 15(d) showed IC50 from 17.39 to 47.10 mu M against human cancer cell lines; hepatocellular carcinoma (HepG2), prostate cancer (PC3), and breast cancer (MCF-7). Meanwhile, the first in terms of VEGFR-2 inhibition was compound 15(d) which came second with regard to antitumor assay with IC50 = 24.10, 40.90, and 33.40 mu M against aforementioned cell lines, respectively. Furthermore, Compound 15(d) increased apoptosis rate of HepG2 from 1.20 to 12.46% as it significantly increased levels of Caspase-3, BAX, and P53 from 49.6274, 40.62, and 42.84 to 561.427, 395.04, and 415.027 pg/mL, respectively. Moreover, 15(d) showed IC50 of 253 and 381 nM against HER2 and FGFR, respectively.
引用
收藏
页码：573 / 591
页数：19
相关论文
共 50 条
  • [41] Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies
    Elkaeed, Eslam B.
    Yousef, Reda G.
    Khalifa, Mohamed M.
    Ibrahim, Albaraa
    Mehany, Ahmed B. M.
    Gobaara, Ibraheem M. M.
    Alsfouk, Bshra A.
    Eldehna, Wagdy M.
    Metwaly, Ahmed M.
    Eissa, Ibrahim H.
    El-Zahabi, Mohamed Ayman
    MOLECULES, 2022, 27 (19):
  • [42] Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives
    Alkamaly, Omkulthom M.
    Altwaijry, Najla
    Sabour, Rehab
    Harras, Marwa F.
    ARCHIV DER PHARMAZIE, 2021, 354 (04)
  • [43] Synthesis and Molecular Docking of Some Novel 3-Thiazolyl-Coumarins as Inhibitors of VEGFR-2 Kinase
    Abolibda, Tariq Z.
    Fathalla, Maher
    Farag, Basant
    Zaki, Magdi E. A.
    Gomha, Sobhi M.
    MOLECULES, 2023, 28 (02):
  • [44] Benzoxazole/benzothiazole-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations
    El-Helby, Abdel-Ghany A.
    Sakr, Helmy
    Eissa, Ibrahim H.
    Al-Karmalawy, Ahmed A.
    El-Adl, Khaled
    ARCHIV DER PHARMAZIE, 2019, 352 (12)
  • [45] Synthesis, biological evaluation and computer-aided discovery of new thiazolidine-2,4-dione derivatives as potential antitumor VEGFR-2 inhibitors
    Elkady, Hazem
    El-Dardir, Osama A.
    Elwan, Alaa
    Taghour, Mohammed S.
    Mahdy, Hazem A.
    Dahab, Mohammed A.
    Elkaeed, Eslam B.
    Alsfouk, Bshra A.
    Ibrahim, Ibrahim M.
    Husein, Dalal Z.
    Hafez, Elsayed E.
    Darwish, Amira M. G.
    Metwaly, Ahmed M.
    Eissa, Ibrahim H.
    RSC ADVANCES, 2023, 13 (40) : 27801 - 27827
  • [46] Design and synthesis of new 2-oxoquinoxalinyl-1,2,4-triazoles as antitumor VEGFR-2 inhibitors
    Zengin, Merve
    Tan, Oya Unsal
    Arafa, Reem
    Balkan, Ayla
    BIOORGANIC CHEMISTRY, 2022, 121
  • [47] Design,synthesis and biological evaluation of O-linked indoles as VEGFR-2 kinase inhibitors(Ⅰ)
    Guo-Rui Gao
    Meng-Yuan Li
    Lin-Jiang Tong
    Li-Xin Wei
    Jian Ding
    Hua Xie
    Wen-Hu Duan
    ChineseChemicalLetters, 2015, 26 (09) : 1165 - 1168
  • [48] Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase Inhibitors
    Lv, Yongcong
    Li, Mengyuan
    Liu, Ting
    Tong, Linjiang
    Peng, Ting
    Wei, Lixin
    Ding, Jian
    Xie, Hua
    Duan, Wenhu
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (05): : 592 - 597
  • [49] Design, synthesis, and biological evaluation of new celecoxib analogs as apoptosis inducers and cyclooxygenase-2 inhibitors
    Abdelhaleem, Eman F.
    Kassab, Asmaa E.
    El-Nassan, Hala B.
    Khalil, Omneya M.
    ARCHIV DER PHARMAZIE, 2022, 355 (11)
  • [50] Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers
    Mahdy, Hazem A.
    Ibrahim, Mohammed K.
    Metwaly, Ahmed M.
    Belal, Amany
    Mehany, Ahmed B. M.
    El-Gamal, Kamal M. A.
    El-Sharkawy, Abdou
    Elnhedawy, Mostafa A.
    Radwan, Mohamed M.
    Elsohly, Mahmoud A.
    Eissa, Ibrahim H.
    BIOORGANIC CHEMISTRY, 2020, 94
12345